Advanced search
Publication Cover
Expert Opinion on Orphan Drugs Volume 1, 2013 - Issue 8
Submit an article Journal homepage
1,494
Views
5
CrossRef citations to date
0
Altmetric
Editorials

Is the increasing cost of treating rare diseases sustainable?

Joshua CohenSenior Research Fellow/Research Assistant Professor, Tufts Center for the Study of Drug Development, 75 Kneeland Street, Suite 1100, Boston, MA 02111, USA+1 617-636-3412; +1 617-636-2425
, PhD &
Christopher-Paul MilneAssociate Director, Tufts Center for the Study of Drug Development, Boston, MA 02111, USA
, DVM MPH JD
Pages 581-583 | Published online: 16 Jul 2013
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Download PDF

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.